this rose to 200m mc, on the initiation of its phase 1 trials.
It doesnt need sales to be launched to multiples. It needs the market to again be displaced by those who take an appetite to the foot print it will leave in the medical diagnostic landscape, and that is measured in multitudes of billions.
- Forums
- ASX - By Stock
- IBX
- Ann: Imagion presents ovarian cancer data at AACR conference
Ann: Imagion presents ovarian cancer data at AACR conference, page-8
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.7¢ |
Change
0.001(2.17%) |
Mkt cap ! $2.022M |
Open | High | Low | Value | Volume |
4.7¢ | 4.7¢ | 4.6¢ | $2.887K | 62.23K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6382 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6382 | 0.047 |
2 | 278491 | 0.046 |
1 | 20000 | 0.045 |
2 | 185000 | 0.044 |
1 | 15000 | 0.043 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 20000 | 1 |
0.056 | 13574 | 1 |
0.060 | 10000 | 1 |
0.063 | 38873 | 1 |
0.070 | 822 | 2 |
Last trade - 12.48pm 08/11/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online